A Study of ASP1002 in Adults for Treatment of Solid Tumors
Clinical trial NCT05719558 · RECRUITING
Trial details
- NCT number
- NCT05719558
- Sponsor
- Astellas Pharma Global Development, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-13
- Primary completion
- 2030-04-30
- Enrollment
- 798
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.